Pete Cotter

Pete Cotter is a seasoned professional in the field of molecular biology and analytical development, currently serving as Director of Molecular Biology and Potency Analytics at Verve Therapeutics since June 2022. Prior experience includes roles as Associate Director and Senior Scientist at Vor Biopharma, and as an Analytical Development Scientist II at CRISPR Therapeutics. Previous positions also include Research Scientist I at Bristol-Myers Squibb, Research Associate at Wyeth, and Research Technologist at Massachusetts General Hospital. Pete Cotter earned a degree from Texas Tech University between 1997 and 2003.